The effect of digoxin on atrioventricular (A-V) conduction-was compared in five patients with an intact cardiac autonomic nervous system (Group I) and seven patients who had undergone cardiac transplantation (Group II), in whom we have previously shown the transplanted heart to be completely denervated.Small decreases in the atrial effective refractory period (ERP) (from 262 ± 12 to 254 ± 11 msec) and atrial functional refractory period (FRP) (from 304 ± 12 msec to 298 + 12 msec) were observed in Group I patients after digoxin, but these changes were not significant. However, significant increases in the A-V nodal ERP (from 315 ± 18 msec to 351 ± 17 msec, P < 0.05), and A-V nodal FRP (from 426 ± 42 to 460 ± 46 msec, P < 0.01) were produced by digoxin and were unrelated to changes in cycle length.
The effect of digoxin on atrioventricular (A-V) conduction-was compared in five patients with an intact cardiac autonomic nervous system (Group I) and seven patients who had undergone cardiac transplantation (Group II), in whom we have previously shown the transplanted heart to be completely denervated.Small decreases in the atrial effective refractory period (ERP) (from 262 ± 12 to 254 ± 11 msec) and atrial functional refractory period (FRP) (from 304 ± 12 msec to 298 + 12 msec) were observed in Group I patients after digoxin, but these changes were not significant. However, significant increases in the A-V nodal ERP (from 315 ± 18 msec to 351 ± 17 msec, P < 0.05), and A-V nodal FRP (from 426 ± 42 to 460 ± 46 msec, P < 0.01) were produced by digoxin and were unrelated to changes in cycle length.
In Group II patients with denervated hearts, changes in atrial ERP (from 246 4 to 243 ± 6 during spontaneous sinus rhythm; from 204 ± 10 to 216 ± 8 msec during atrial pacing) and atrial FRP (from 311 ± 12 to 316 + 11 msec during spontaneous sinus rhythm; from 254 ± 12 to 260 ± 10 msec during atrial pacing) were not significant. However, in contrast to the Group I patients, the digoxin-induced changes in A-V nodal ERP (from 280 ± 22 to 297 ± 18 msec during atrial pacing) and FRP (from 368 ± 18 to 377 18 msec during spontaneous sinus rhythm; from 334 ± 13 to 346 ± 16 msec during atrial pading) were also statistically insignificant.
Our results demonstrate that the electrophysiologic effects of digoxin on atrioventricular conduction in man are most marked in the atrioventricular node and are dependent on cardiac innervation.
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Autonomic nervous system Digitalis Transplant THE MECHANISMS by which digitalis affects atrioventricular (A-V) conduction have been a matter of continuing controversy. At least three contributing factors have been proposed including changes in vagal tone, alterations of the sympathetic nervous system, and direct effects of the glycoside.1-5 Studies in man have usually been limited to persons with known heart disease in whom an intact autonomic nervous system is present, or to those patients in whom drug-induced blockade of components of the autonomic nervous system has been effected.4' 68 Such studies make it difficult to separate the direct electrophysiologic effects of glycosides from those mediated via the autonomic nervous system. Cardiac transplantation has provided us with a unique opportunity to study the functionally normal human heart in the denervated state.9' 10 The purpose of this study was to assess the effect of digitalis on A-V conduction in such patients. pressive therapy of corticosteroids and azathioprine. Their weights ranged from 78.6 to 86.4 kg and their serum creatines ranged from 0.8 to 1.2 mg%. The transplanted heart, both at the time of surgery and in subsequent followup studies, has been shown to be normal except for its denervated state.9'`The resting ECG and baseline intracardiac conduction intervals were within normal limits except for patient 3 Refractory periods were determined using the extra stimulus technique. Beginning late in the cardiac cycle, a premature atrial stimulus (S,) was introduced after everv eighth spontaneous sinus beat (Group I and Group II) or driven atrial beat (S,) (Group II only). The prematurity of the S2 was decreased in 20 msec steps until the atrial refractory period was encountered, so that the entire atrial cycle was scanned. After control measurements were obtained, digoxin 1 .25 mg i.v. was given over a five-minute period, and the experimental procedure repeated 45 minutes to one hour later. At the termination of the study, amyl nitrite and atropine were administered to Group II patients for evaluation of autonomic innervation, and blood was drawn for determination of the digoxin level 60 to 90 min after its administration. Serum digoxin level in all patients was greater than 5 ng/ml as expected after its acute administration.
Measurements of intracardiac conduction intervals and refractory periods were accomplished according to standard techniques.'2 A,, H,, and V, are the atrial, His, and ventricular electrograms resulting from either spontaneous sinus beats or driven atrial beats (S,). A,, H2, and V2 represent the atrial, His, and ventricular electrograms resulting from a premature atrial stimulus (S2).
The refractory periods for the A-V conduction system were defined as:
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In the denervated transplant patients, studies during regular sinus rhythm allowed the determination of the A-V nodal ERP in only three patients due to the limitations of the atrial FRP. However, in these three patients the mean A-V nodal ERP of 340 msec was unchanged by digitalis administration (table 3). During atrial pacing the A-V nodal ERP could be determined in four of seven patients before, and six of seven patients after digoxin administration, increasing in four of six. However, if we assume that the A-V nodal ERP was equal to the atrial FRP in patients 3 and 5 before digoxin, the change in A-V nodal ERP fro--.i 280 ± 22 to 297 ± 18 msec did not reach statistical significance (table 4) .
The A-V nodal FRP was determined before and after digoxin in five Group II patients during spontaneous sinus rhythm. The increase noted after digoxin was not significant (table 3) (300 msec), the increase in A-V nodal FRP was also not significant (table 4) . It should be noted that resting cycle length did not change in any patient after digoxin administration. Figure 2 illustrates the effect of digoxin, 1.25 mg i.v., on the A-V nodal ERP and FRP during spontaneous rhythm in denervated patient number 7. Note that there is no significant change in A-V nodal ERP or FRP after digitalis. After the administration of amyl nitrite to the transplant patients, only a small (< 5%) increase in donor heart rate was produced. Atropine, 1.5 mg i.v., produced no change in donor heart rate. These results confirm the autonomic denervation in these patients.
Discussion
Digitalis preparations have been shown to affect atrioventricular conduction both in animals and man.'-4, 6 In the innervated (intact) human heart, ouabain4 has been shown to increase the P-R interval during atrial pacing when compared to control measurements, but after atropine this effect was abolished.8 Digoxin has been shown to increase both the effective and functional refractory period of the A-V node in the innervated human heart.6 In the dog, Mendez and Mendez' demonstrated an increase in A-V nodal refractory periods after digitalis, and in the acutely denervated preparation found similar results. Schaal et al. 5 have shown that in the chronically denervated dog heart the functional refractory period of the A-V node is identical before and after digoxin. The findings of Morrow et al. in dogs suggested antiadrenergic, vagomimetic, and direct effects of ouabain. 3 The transplanted human heart offers us a unique opportunity to study the electrophysiologic effects of cardioactive drugs. The heart is normal anatomically and functionally, as demonstrated at the time of surgery and at routine yearly examinations, except that it lacks neural innervation.9' 10 Thus, it offers an ideal situation for distinguishing direct drug effects from those mediated by stimulation of the autonomic nervous system either directly or secondary to reflex adjustments. Circulating catecholamines may also directly affect A-V conduction.`4 However, changes in the catecholamine environment did not seem to take place during the studies in transplant patients as judged by a constant heart rate during the entire procedure (table 1) .
In both the Group I and Group II patients, digoxin administration had no statistically significant effect on the atrial effective or functional refractory period. The small, insignificant increase in both parameters in Group 1 patients may have been related to the similarly insignificant increase in cycle length after digoxin. Denes et al. have shown that increases in cycle length are accompanied by an increase in atrial effective and functional refractory period. 15 Alternately, it is possible that because of the postulated opposing autonomic and direct effect of digoxin in the atrium, with the autonomic effect usually predominant, this small change is to be expected. However, only with a larger test group could statistical significance be reached. In Group II patients, in whom the direct effect unopposed by autonomic factors should be more obvious, no significant change in atrial refractory periods could be demonstrated.
In contrast to the minimal electrophysiologic effect in the atrium, digoxin produced significant increases in the A-V nodal effective and functional refractory periods in Group I patients. This may be the result of the influence of digoxin on the autonomic system (vagotonus and sympatholysis) with ultimately a direct effect on the A-V node. In evaluating these drug effects in patients with an innervated, diseased heart it should be remembered that both the underlying autonomic tone and the magnitude of the reflex changes are probably abnormal, and these factors are probably of prime importance in determining the patient's response to digitalis glycosides. 7' 1618 In contrast to the group of five patients with intact cardiac reflexes, no significant effect of digoxin could be demonstrated on A-V nodal refractory periods in the seven patients with transplanted, denervated hearts. Determination of the A-V nodal ERP during the patient's spontaneous sinus rhythm could be made in only three patients before and after digoxin, so that statistical analysis was not performed on the data. However, it is possible that the small, insignificant increases in the A-V nodal ERP found during pacing, and the A-V nodal FRP determined during both sinus rhythm and pacing, represent small direct effects of the drug. Again, a larger study group might show the direct effects of digoxin to be important.
In summary, this study has documented the contrasting effect of an acutely administered cardiac glycoside, digoxin, on A-V nodal conduction in patients with a transplanted, denervated human heart when compared to patients with intact cardiac reflexes. In the intact heart, digoxin has been shown to prolong the A-V nodal ERP and FRP irrespective of changes in the cycle length, while in the transplanted heart no statistically significant effects could be demonstrated after acute administration. It is of note that while the study was conducted 45 minutes to 1 hour after the administration of digoxin, so that autonomic effects would be expected to have occurred within the period of observation, later direct effects on the A-V node cannot be excluded. In addition, the patients had been taking no glycosides prior to study and had received an acute bolus of digoxin. It may be that study after chronic administration of the drug would reveal direct electrophysiologic effects on A-V nodal conduction.
These results are applicable to patients with heart disease, especially those with congestive failure. In patients with heart disease, parasympathetic responsiveness is reduced. 16 Congestive heart failure both in the experimental animal and in man impairs the cardiac responsiveness to sympathetic stimulation. 17 18 This reduction in autonomic responsiveness finds its ultimate expression in the transplanted heart.9' 10 It would be expected, therefore, that the effect of digitalis on atrioventricular conduction by way of its primary autonomic actions would be blunted in patients with heart disease, especially those with congestive failure. This may help to explain situations in which the amount of slowing of the ventricular response to atrial fibrillation after digitalis administration in patients with congestive heart failure is unexpectedly small.
